Johnson & Johnson is offering up to $5.5 billion to settle about 76,000 baby powder lawsuits tied to ovarian cancer claims.
Johnson & Johnson is offering a baby powder settlement worth as much as $5.5 billion to end tens of thousands of U.S. lawsuits that accuse its talc products of causing ovarian cancer. The proposed deal is one of the biggest steps yet in a legal fight that has shadowed the New Jersey-based company for years and kept pressure on one of its best-known consumer brands.
The company said the plan would cover about 76,000 cases and would resolve most of the remaining talc-related claims. Under the proposal, J&J would put up to $3 billion on the table next year, with no further payments required before 2028. The agreement still needs the backing of legal firms representing 95% of the ovarian cancer claims in state and federal court before it can be completed.
Erik Haas, J&J’s vice president of litigation, said the allegations were meritless and said the company was prepared to settle so the dispute can finally be closed. He also said J&J believed it would have ultimately won with more litigation, pointing to the company’s record in most of the cases heard so far. In his statement, Haas said the proposed resolution would let the company move past the matter and stay focused on medicines and devices that save lives.
J&J has long denied that its talc-based products caused cancer. The company says studies show talc is safe, does not contain asbestos and does not cause cancer. It has also changed the formula of its baby powder. In 2022, J&J said it would stop making and selling talc-based baby powder worldwide, more than two years after ending U.S. sales and shifting to an all cornstarch-based baby powder portfolio.
“Johnson & Johnson is offering up to $5.5 billion to settle about 76,000 baby powder lawsuits tied to ovarian cancer claims.”
The dispute stretches back years. Lawsuits over J&J’s talc baby powder began as early as 2009, with consumers and survivors claiming the product caused cancer because of asbestos contamination. J&J argues that talc is a natural mineral often used in baby powder and that the claims do not hold up. A federal court handed the company a win earlier in July when it questioned whether individual plaintiffs could show talc was the direct cause of their ovarian cancer.
One important detail in the wider dispute is that J&J’s former consumer health business, Kenvue, holds liability for Johnson’s baby powder outside North America. Kenvue, which owns brands including Band-Aid, Listerine and Calpol, was spun off from J&J in 2022. That split means the baby powder fight is now part of a broader corporate cleanup that still reaches across old product lines and current legal exposure.
For American readers, the baby powder settlement matters because it shows how long-running product-liability fights can reshape a major company, even when the company insists it did nothing wrong. The next key step is whether the required legal support comes through, which would determine whether this settlement becomes the final chapter or just another turn in a case that has already lasted far too long.
Frequently asked questions
How much is Johnson & Johnson offering in the settlement?
J&J is offering a settlement worth as much as $5.5 billion. The company said it would put up to $3 billion on the table next year, with no further payments required before 2028.
How many lawsuits would the deal cover?
The company said the proposal would cover about 76,000 cases. It would resolve most of the remaining talc-related claims.
What has J&J said about the cancer allegations?
J&J says the allegations are meritless and has long denied that its talc-based products caused cancer. The company says studies show talc is safe, does not contain asbestos and does not cause cancer.
What still has to happen before the settlement is final?
The proposal needs backing from legal firms representing 95% of the ovarian cancer claims in state and federal court before it can be completed.
We value your privacy 🍪We use cookies for essential features and, if you allow it, to send you a notification whenever we publish a new story. See our Privacy Policy.
📨
Never Miss a Story
Get the headlines that matter delivered straight to your inbox.
📱 On iPhone: tap the Share icon, choose “Add to Home Screen”, then open TheTrueDefender from your Home Screen and tap 🔔 to turn on notifications. (Apple only allows notifications for saved web apps.)
📱 Add TheTrueDefender to your home screen for one-tap access.
